Metabolomic Assessment of Embryo Viability

dc.contributor.author Uyar, Asli
dc.contributor.author Seli, Emre
dc.date.accessioned 2024-05-25T11:24:07Z
dc.date.available 2024-05-25T11:24:07Z
dc.date.issued 2014
dc.description Uyar, Asli/0000-0002-7913-1083 en_US
dc.description.abstract Preimplantation embryo metabolism demonstrates distinctive characteristics associated with the developmental potential of embryos. On this basis, metabolite content of culture media was hypothesized to reflect the implantation potential of individual embryos. This hypothesis was tested in consecutive studies reporting a significant association between culture media metabolites and embryo development or clinical pregnancy. The need for a noninvasive, reliable, and rapid embryo assessment strategy promoted metabolomics studies in vitro fertilization (IVF) in an effort to increase success rates of single embryo transfers. With the advance of analytical techniques and bioinformatics, commercial instruments were developed to predict embryo viability using spectroscopic analysis of surplus culture media. However, despite the initial promising results from proof-of-principal studies, recent randomized controlled trials using commercial instruments failed to show a consistent benefit in improving pregnancy rates when metabolomics is used as an adjunct to morphology. At present, the application of metabolomics technology in clinical IVF laboratory requires the elimination of factors underlying inconsistent findings, when possible, and development of reliable predictive models accounting for all possible sources of bias throughout the embryo selection process. en_US
dc.description.sponsorship National Institutes of Health (NIH) [R01HD059909] en_US
dc.description.sponsorship E.S. is supported by award no. R01HD059909 from the National Institutes of Health (NIH). en_US
dc.identifier.citationcount 48
dc.identifier.doi 10.1055/s-0033-1363556
dc.identifier.issn 1526-8004
dc.identifier.issn 1526-4564
dc.identifier.scopus 2-s2.0-84907623415
dc.identifier.uri https://doi.org/10.1055/s-0033-1363556
dc.identifier.uri https://hdl.handle.net/20.500.14517/759
dc.language.iso en
dc.publisher Thieme Medical Publ inc en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject embryo assessment en_US
dc.subject metabolomics en_US
dc.title Metabolomic Assessment of Embryo Viability en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Uyar, Asli/0000-0002-7913-1083
gdc.author.institutional Uyar A.
gdc.author.scopusid 55664907400
gdc.author.scopusid 6701473546
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.description.department Okan University en_US
gdc.description.departmenttemp [Uyar, Asli; Seli, Emre] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Uyar, Asli] Okan Univ, Dept Comp Engn, Istanbul, Turkey en_US
gdc.description.endpage 151 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 141 en_US
gdc.description.volume 32 en_US
gdc.description.wosquality Q3
gdc.identifier.pmid 24515909
gdc.identifier.wos WOS:000331288800010
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.scopus.citedcount 50
gdc.wos.citedcount 45

Files